ZimVie, Zimmer Biomet's spinoff company, plans to use a new partnership to strengthen its spine business, President and CEO Vafa Jamali said in a March 1 earnings call.
ZimVie plans to partner with Brainlab to support its spine technologies, Mr. Jamali said, as transcribed by Motley Fool. The partnership will focus on imaging, planning, navigation and robot-assisted tools.
"Work is already underway to integrate our minimally invasive Vital and Virage systems into Brainlab's innovative solutions, allowing us to bring differentiated technology into the operating room to enhance workflow and accuracy while reducing intraoperative x-rays and radiation exposure," Mr. Jamali said. "At the time of the spin, I announced that we would partner, rather than build, an enabling technology offering with an established leader in the space, and Brainlab fits exactly with our strategy to leverage broadly compatible solutions with an established footprint to drive greater pull-through across our spine portfolio."
ZimVie posted fourth-quarter sales of $228.2 million, and its 2022 sales were just over $900 million.